See more : Spring Valley Acquisition Corp. II (SVIIU) Income Statement Analysis – Financial Results
Complete financial analysis of Roche Holding AG (RO.SW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Roche Holding AG, a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
You may be interested
- Pulsar Group plc (PULS.L) Income Statement Analysis – Financial Results
- SBI Sumishin Net Bank, Ltd. (7163.T) Income Statement Analysis – Financial Results
- VAT Group AG (0RFL.L) Income Statement Analysis – Financial Results
- Genomma Lab Internacional, S.A.B. de C.V. (LABB.MX) Income Statement Analysis – Financial Results
- SeAH Steel Corporation (306200.KS) Income Statement Analysis – Financial Results
Roche Holding AG (RO.SW)
About Roche Holding AG
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 60.44B | 63.28B | 62.80B | 58.32B | 63.75B | 59.50B | 55.75B | 52.64B | 50.40B | 49.87B | 48.61B | 45.50B | 42.53B | 47.47B | 49.05B | 45.62B | 46.13B | 42.04B | 35.51B | 31.27B | 31.22B | 29.73B | 29.16B | 28.67B | 27.57B | 24.66B |
| Cost of Revenue | 16.36B | 18.84B | 19.70B | 16.35B | 17.39B | 16.52B | 15.89B | 15.08B | 14.25B | 12.98B | 12.38B | 12.18B | 11.94B | 13.29B | 14.62B | 13.66B | 13.74B | 10.62B | 9.30B | 7.18B | 8.32B | 8.43B | 8.34B | 9.16B | 8.87B | 7.90B |
| Gross Profit | 44.08B | 44.44B | 43.10B | 41.97B | 46.37B | 42.98B | 39.86B | 37.56B | 36.16B | 36.89B | 36.23B | 33.32B | 30.59B | 34.18B | 34.44B | 31.96B | 32.39B | 31.43B | 26.21B | 24.09B | 22.91B | 21.29B | 20.82B | 19.51B | 18.69B | 16.76B |
| Gross Profit Ratio | 72.94% | 70.23% | 68.63% | 71.96% | 72.73% | 72.23% | 71.50% | 71.35% | 71.74% | 73.97% | 74.54% | 73.24% | 71.92% | 72.00% | 70.20% | 70.05% | 70.21% | 74.75% | 73.80% | 77.03% | 73.37% | 71.63% | 71.41% | 68.04% | 67.81% | 67.96% |
| Research & Development | 14.20B | 14.05B | 13.71B | 12.15B | 12.77B | 12.09B | 11.29B | 11.53B | 9.58B | 9.90B | 9.27B | 9.55B | 8.33B | 10.03B | 9.87B | 8.85B | 8.39B | 6.59B | 5.71B | 5.09B | 4.77B | 4.26B | 3.89B | 3.95B | 3.78B | 3.41B |
| General & Administrative | 14.88B | 14.20B | 2.43B | 2.46B | 2.49B | 2.59B | 2.36B | 1.15B | 2.15B | 2.21B | 2.11B | 3.05B | 2.34B | 2.87B | 2.18B | 2.33B | 2.45B | 2.54B | 11.91B | 10.41B | 10.30B | 9.83B | 9.67B | 9.99B | 8.99B | 7.83B |
| Selling & Marketing | 0.00 | 9.64B | 9.48B | 9.39B | 10.55B | 9.94B | 9.52B | 9.01B | 8.61B | 8.44B | 8.25B | 8.54B | 8.05B | 9.49B | 9.48B | 9.17B | 9.33B | 10.86B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 14.88B | 12.03B | 11.87B | 11.82B | 13.18B | 12.67B | 12.03B | 10.34B | 10.94B | 10.84B | 10.59B | 11.59B | 10.39B | 12.36B | 11.65B | 11.50B | 11.78B | 13.40B | 11.91B | 10.41B | 10.30B | 9.83B | 9.67B | 9.99B | 8.99B | 7.83B |
| Other Expenses | -392.00M | -192.00M | -238.00M | -265.00M | -227.00M | -197.00M | -311.00M | -316.00M | 0.00 | 0.00 | 0.00 | -1.93B | -1.57B | -1.67B | -2.08B | -2.29B | -2.24B | -277.00M | -80.00M | -389.00M | 2.25B | 5.87B | 4.01B | -1.56B | -497.00M | 1.16B |
| Operating Expenses | 28.69B | 26.27B | 25.82B | 24.24B | 29.23B | 28.26B | 27.04B | 23.87B | 23.31B | 23.46B | 20.50B | 19.21B | 17.15B | 20.71B | 19.45B | 18.06B | 17.92B | 19.71B | 17.54B | 15.11B | 17.31B | 19.96B | 17.58B | 12.38B | 12.27B | 12.39B |
| Cost & Expenses | 45.05B | 45.11B | 45.52B | 40.59B | 46.62B | 44.78B | 42.93B | 38.95B | 37.56B | 36.44B | 32.88B | 31.39B | 29.09B | 34.01B | 34.06B | 31.72B | 31.67B | 30.33B | 26.84B | 22.29B | 25.63B | 28.39B | 25.92B | 21.54B | 21.15B | 20.29B |
| Interest Income | 195.00M | 568.00M | 342.00M | 16.00M | 520.00M | 574.00M | 566.00M | 683.00M | 859.00M | 909.00M | 1.06B | 32.00M | 73.00M | 51.00M | 179.00M | 698.00M | 1.07B | 788.00M | 423.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 997.00M | 608.00M | 341.00M | 438.00M | 620.00M | 605.00M | 598.00M | 707.00M | 1.11B | 1.18B | 1.33B | 2.00B | 2.01B | 2.55B | 2.44B | 214.00M | 281.00M | 315.00M | 326.00M | 0.00 | 1.08B | 4.52B | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 3.46B | 3.82B | 4.45B | 4.57B | 4.31B | 3.60B | 3.89B | 3.95B | 3.59B | 2.62B | 2.38B | 2.42B | 2.37B | 2.55B | 2.69B | 2.65B | 2.54B | 2.44B | 1.01B | 1.61B | 1.51B | 1.52B | 1.55B | 2.85B | 2.45B | 2.07B |
| EBITDA | 18.41B | 20.80B | 22.19B | 22.97B | 21.56B | 18.34B | 16.74B | 17.67B | 19.05B | 19.13B | 18.15B | 16.01B | 15.72B | 15.66B | 14.71B | 17.02B | 18.13B | 15.38B | 11.80B | 10.58B | 7.10B | 2.86B | 4.80B | 27.57B | 8.87B | 6.44B |
| EBITDA Ratio | 30.46% | 34.76% | 34.60% | 38.23% | 39.17% | 37.83% | 38.00% | 39.25% | 37.79% | 38.37% | 39.06% | 37.30% | 38.48% | 34.69% | 37.52% | 36.12% | 37.31% | 33.97% | 27.26% | 33.84% | 22.75% | 9.60% | 16.46% | 34.80% | 32.19% | 26.13% |
| Operating Income | 15.40B | 18.18B | 17.28B | 17.73B | 21.03B | 18.92B | 17.30B | 16.85B | 15.46B | 16.51B | 16.61B | 14.13B | 13.45B | 13.49B | 12.28B | 13.92B | 14.47B | 11.73B | 8.67B | 8.98B | 5.59B | 1.34B | 3.25B | 7.13B | 6.42B | 4.37B |
| Operating Income Ratio | 25.47% | 28.72% | 27.52% | 30.40% | 32.99% | 31.80% | 31.03% | 32.01% | 30.67% | 33.11% | 34.17% | 31.04% | 31.63% | 28.41% | 25.03% | 30.52% | 31.36% | 27.90% | 24.41% | 28.71% | 17.91% | 4.49% | 11.13% | 24.87% | 23.29% | 17.72% |
| Total Other Income/Expenses | -1.32B | -1.11B | 117.00M | -577.00M | -934.00M | -621.00M | -755.00M | -1.06B | -1.83B | -1.58B | -1.70B | -1.80B | -1.57B | -2.28B | -2.05B | 236.00M | 836.00M | 857.00M | 133.00M | 4.25B | -711.00M | -4.53B | 1.52B | 2.34B | 1.13B | 1.08B |
| Income Before Tax | 14.08B | 16.37B | 17.40B | 17.97B | 16.61B | 14.15B | 12.25B | 13.01B | 11.99B | 12.52B | 14.68B | 12.32B | 11.89B | 11.21B | 10.23B | 14.16B | 15.30B | 12.59B | 8.97B | 9.49B | 4.88B | -3.19B | 4.76B | 9.47B | 7.56B | 5.45B |
| Income Before Tax Ratio | 23.29% | 25.87% | 27.71% | 30.80% | 26.06% | 23.78% | 21.97% | 24.71% | 23.78% | 25.10% | 30.19% | 27.08% | 27.94% | 23.62% | 20.86% | 31.04% | 33.17% | 29.94% | 25.25% | 30.33% | 15.63% | -10.75% | 16.33% | 33.02% | 27.41% | 22.11% |
| Income Tax Expense | 1.72B | 2.80B | 2.46B | 2.90B | 2.51B | 3.28B | 3.42B | 3.27B | 2.93B | 2.98B | 3.30B | 2.55B | 2.34B | 2.32B | 1.72B | 3.32B | 3.87B | 3.44B | 2.22B | 2.35B | 1.45B | 839.00M | 1.04B | 2.27B | 1.90B | 965.00M |
| Net Income | 11.50B | 12.42B | 13.93B | 14.30B | 13.50B | 10.50B | 8.63B | 9.58B | 8.86B | 9.33B | 11.16B | 9.54B | 9.34B | 8.67B | 7.78B | 8.97B | 9.76B | 7.88B | 6.73B | 6.64B | 3.07B | -4.03B | 3.70B | 8.65B | 5.76B | 4.39B |
| Net Income Ratio | 19.02% | 19.63% | 22.18% | 24.51% | 21.17% | 17.65% | 15.49% | 18.19% | 17.58% | 18.71% | 22.97% | 20.97% | 21.97% | 18.25% | 15.87% | 19.66% | 21.16% | 18.74% | 18.95% | 21.24% | 9.83% | -13.54% | 12.68% | 30.16% | 20.91% | 17.81% |
| EPS | 14.39 | 15.53 | 16.39 | 16.72 | 15.77 | 12.30 | 10.12 | 11.24 | 10.41 | 10.99 | 13.17 | 11.12 | 11.01 | 10.14 | 9.07 | 10.43 | 11.36 | 9.24 | 7.01 | 7.86 | 3.66 | -4.80 | 4.40 | 10.29 | 6.68 | 5.09 |
| EPS Diluted | 14.30 | 15.53 | 16.20 | 16.52 | 15.62 | 12.21 | 10.04 | 11.13 | 10.28 | 10.81 | 12.94 | 11.03 | 10.98 | 10.11 | 9.02 | 10.23 | 11.16 | 9.05 | 6.87 | 7.77 | 3.61 | -4.80 | 4.37 | 10.24 | 6.68 | 5.09 |
| Weighted Avg Shares Out | 799.00M | 800.00M | 850.00M | 855.00M | 856.00M | 854.00M | 853.00M | 852.00M | 851.00M | 849.00M | 848.00M | 848.00M | 849.00M | 855.00M | 858.00M | 860.00M | 859.00M | 852.00M | 845.00M | 840.46M | 839.00M | 838.75M | 840.23M | 840.23M | 862.87M | 862.87M |
| Weighted Avg Shares Out (Dil) | 804.00M | 800.00M | 860.00M | 865.00M | 864.00M | 860.00M | 860.00M | 860.00M | 862.00M | 863.00M | 863.00M | 855.00M | 851.00M | 857.00M | 859.00M | 861.00M | 862.00M | 862.00M | 860.00M | 850.19M | 850.14M | 838.75M | 862.87M | 844.43M | 862.87M | 862.87M |
No news found for: RO.SW
Source: https://incomestatements.info
Category: Stock Reports